SOUTH SAN FRANCISCO, Calif., Jan. 11, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, provided a business update including an overview of ...
As companies face increased scrutiny all along the supply chain, including from regulators, customers, investors, and the public, one thing is clear: failure to consider environmental justice ...
1 Enter a joint venture agreement on the KSM project with a suitable partner on terms advantageous to Seabridge shareholders 20.5 2 Secure a minimum of $50 million in new funding to continue to ...
MONTREAL, June 17, 2021 /CNW Telbec/ - Boralex Inc. ("Boralex" or the "Company") (TSX: BLX) today unveiled its updated strategic plan and introduced new corporate objectives for 2025 at its 2021 ...
PERTH, Australia and NEW YORK, Feb. 22, 2021 /PRNewswire/ — PYC Therapeutics (ASX: PYC), a biotechnology company developing a new generation of precision RNA therapeutics to change the lives of ...
Toronto, Ontario--(Newsfile Corp. - February 10, 2026) - For more than 20 years, Seabridge Gold (TSX: SEA) (NYSE: SA) has set and published annual objectives and reported on the results at the end of ...
There is a compelling call for corporates and business institutions to deeply engage with the rapidly changing dynamics of our world, particularly in how they deliberately drive their Corporate Social ...
SOUTH SAN FRANCISCO, Calif., Jan. 11, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, provided a business update including an overview of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results